Unknown

Dataset Information

0

Loss of Dnmt3a increases self-renewal and resistance to pegIFN-α in JAK2-V617F–positive myeloproliferative neoplasms∗

ABSTRACT:

SUBMITTER: Usart M 

PROVIDER: S-EPMC11208296 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Reversine exhibits antineoplastic activity in JAK2<sup>V617F</sup>-positive myeloproliferative neoplasms.
| S-EPMC6616334 | biostudies-literature
Unknown A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms.
| S-EPMC3676425 | biostudies-literature
Unknown Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis.
| S-EPMC4986524 | biostudies-literature
Unknown SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.
| S-EPMC3672250 | biostudies-literature
Unknown Concomitant Myeloproliferative and Lymphoid Neoplasms in Two Patients Positive for JAK2 V617F Mutation. Case Report and Literature Review.
| S-EPMC4192220 | biostudies-literature
Transcriptomics Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis
2016-06-24 | GSE82074 | GEO
Unknown Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms.
| S-EPMC5085254 | biostudies-literature
Unknown Hmga2 collaborates with <i>JAK2</i>V617F in the development of myeloproliferative neoplasms.
| S-EPMC5728313 | biostudies-literature
Transcriptomics Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis
2016-06-24 | E-GEOD-82074 | biostudies-arrayexpress
Unknown TET2, DNMT3A, IDH1, and JAK2 Mutation in Myeloproliferative Neoplasms in southern Iran.
| S-EPMC9013495 | biostudies-literature